North America Over-the-Counter (OTC) Drugs Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Over-the-counter(OTC) medicine is also known as OTC or nonprescription medicine. All these terms refer to that medicine because you can buy without a prescription. They are safe and effective when you follow the directions on the label and as directed by your healthcare professional.

North America Over-the-Counter (OTC) Drugs Market Share:

Compared to the past years, Over-the-Counter devices have undergone a predominant change in the markets of North America. The Product Type segment is expected to have the highest growth rate in the  market

North America Over-the-Counter (OTC) Drugs Market Size & Growth:

The North American market for Over-the-Counter drugs is estimated to be USD 36.19 Billion in 2018 and is expected to reach USD 41.85 billion by the end of 2024. During this period, the market is expected to grow at a CAGR of 2.99%.

There is a wide range of Products in Over-the-Counter Drugs Market such as Cough and Cold, Vitamin, Minerals and Supplements, Analgesics, and Digestive Products. As there are enormous applications, the market size related to OTC is even more prominent in  North America. The USA holds the most significant share in the market. Following the USA, Canada is the second biggest market in North America, followed by Mexico.

Growing demand for the use of medication for minor health issues that do not require a doctor’s visit, Increased awareness among the population regarding the potential benefits of using the OTC drugs, Potential savings made by the healthcare industry on a yearly basis, Growing inclination from the pharmaceutical industries to convert their products from Rx to OTC category are some of the significant factors contributing to the growth of North America Over-the-Counter Drugs Market.

North America Over-the-Counter (OTC) Drugs Market Industry Analysis:

The North America Over-the-Counter Drugs market has been segmented by product type, which is sub-segmented into digestive products, vitamins, minerals and supplements, analgesics, cough and cold, and others.

North America Over-the-Counter (OTC) Drugs Market Outlook:

Although the market share is high in the North American region, the USA’s share is less when compared to the other countries on a global forefront. This condition is due to the strict regulatory measures taken by the US government in the labelling of drugs as OTC.  But in recent times, there has been a change in opinion regarding the Over-The-Counter market.

North America Over-the-Counter (OTC) Drugs Market Trends:

• P&G was named as one of America’s Most JUST Companies, according to Forbes and JUST Capital, a nonprofit that ranks the largest publicly traded corporations in the United States on the issues Americans care about most.
• GSK and Medicines for Malaria Venture announced the submission of a regulatory application by GSK to the Australian Therapeutics Good Administration seeking approval of single-dose tafenoquine treatment for the radical cure of Plasmodium vivax malaria.

North America Over-the-Counter (OTC) Drugs Market Research report includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
• Identifying DROC in the current market and their impact in altering the market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the major market players, such as
• GlaxoSmithKline
• Reckitt Benckiser
• Procter & Gamble
• Bristol-Myers Squibb
• Boehringer Ingelheim GmbH